search
Back to results

Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant (HPI2022) (HPI2022)

Primary Purpose

Hypotension During Surgery, Kidney Transplant; Complications

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
ACUMEN (Edwards Lifesciences, Irvine, USA)
Invasive Blood Pressure
Sponsored by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypotension During Surgery focused on measuring HPI

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • First single or double kidney transplant from a cadaveric donor;
  • ASA Class III-IV;
  • Signature of informed consent.

Exclusion Criteria:

  • Patient with atrial fibrillation rhythm or high frequency tachyarrhythmias;
  • Severe valvulopathies;
  • Combined single/double kidney-liver-transplant;
  • Patients in whom the need for monitoring would still be expected advanced, invasive or minimally invasive hemodynamic, regardless of the allocation to the study group;
  • Inclusion in another study.

Sites / Locations

  • IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

HPI group

Control group

Arm Description

Conventional therapy and monitoring with ACUMEN sensor (Edwards Lifesciences, Irvine, USA) and Hemosphere platform (Edwards Lifesciences, Irvine, USA) of invasive blood pressure. Strategy to prevent hypotension based on HPI index, Eadyn and dP/dTmax.

Conventional therapy according to standard monitoring in the operating room which includes invasive blood pressure monitoring.

Outcomes

Primary Outcome Measures

Intra-operative hypotension time
Hypotension (MAP < 65 mmHg) time relative to the range from 20 minutes after induction to the end of surgery

Secondary Outcome Measures

Post-operative hypotension time
Hypotension (MAP < 65 mmHg) time relative to the range from the end of surgery to the first 12 hours after surgery
Intra-operative severe hypotension time
Severe hypotension (MAP < 50 mmHg) time relative to the range from 20 minutes after induction to the end of surgery
Major Adverse Cardiovascular Events (MACE)
Number of major cardiovascular complications (MACE) within the first five days after kidney transplantation (for MACE the composite endpoint of heart attack is considered heart failure, heart failure or presumed cardiac death)
Hospital mortality
Number of patient died in the first 30 days after surgery
Intensive Care Unit Length of Stay
Number of hours of ICU admission
Hospital Length of Stay
Number of days before hospital discharge
Delayed Graft Function (DGF)
Need for hemodialysis in first 7 postoperative days
Graft survival
Post-operative delirium
CAM-ICU positive (asses one time for a day in the first 5 postoperative days)

Full Information

First Posted
May 22, 2022
Last Updated
January 13, 2023
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
search

1. Study Identification

Unique Protocol Identification Number
NCT05394896
Brief Title
Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant (HPI2022)
Acronym
HPI2022
Official Title
Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant: an Explorative, Monocentric, RCT
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2022 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
HPI monitoring and the adoption of therapeutic interventions before hypotension occurs should be ensure a shorter time of intra-operative hypotension (MAP < 65 mmHg) during deceased-donor kidney transplant surgery. The control group is represented by patients undergoing the same surgical procedure with hemodynamic monitoring with invasive blood pressure monitoring which represents the gold standard for this surgery. HPI monitoring has not yet been investigated during this surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension During Surgery, Kidney Transplant; Complications
Keywords
HPI

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
46 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
HPI group
Arm Type
Experimental
Arm Description
Conventional therapy and monitoring with ACUMEN sensor (Edwards Lifesciences, Irvine, USA) and Hemosphere platform (Edwards Lifesciences, Irvine, USA) of invasive blood pressure. Strategy to prevent hypotension based on HPI index, Eadyn and dP/dTmax.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Conventional therapy according to standard monitoring in the operating room which includes invasive blood pressure monitoring.
Intervention Type
Device
Intervention Name(s)
ACUMEN (Edwards Lifesciences, Irvine, USA)
Intervention Description
ACUMEN sensor generates HPI index which should predict hypotension. Based on HPI index, Eadyn and dP/dTmax values anaesthesia should somministrate liquid or drugs to prevent hypotension.
Intervention Type
Device
Intervention Name(s)
Invasive Blood Pressure
Intervention Description
Invasive Blood Pressure permits continue monitoring of blood pressure (routine standard for kidney transplant surgery)
Primary Outcome Measure Information:
Title
Intra-operative hypotension time
Description
Hypotension (MAP < 65 mmHg) time relative to the range from 20 minutes after induction to the end of surgery
Time Frame
From 20 minutes after anaesthesia induction to the end of surgery (intra-operative)
Secondary Outcome Measure Information:
Title
Post-operative hypotension time
Description
Hypotension (MAP < 65 mmHg) time relative to the range from the end of surgery to the first 12 hours after surgery
Time Frame
From the end of surgery to the first 12 hours after surgery (post-operative)
Title
Intra-operative severe hypotension time
Description
Severe hypotension (MAP < 50 mmHg) time relative to the range from 20 minutes after induction to the end of surgery
Time Frame
From 20 minutes after anaesthesia induction to the end of surgery (intra-operative)
Title
Major Adverse Cardiovascular Events (MACE)
Description
Number of major cardiovascular complications (MACE) within the first five days after kidney transplantation (for MACE the composite endpoint of heart attack is considered heart failure, heart failure or presumed cardiac death)
Time Frame
First 5 post-operative days after surgery (post-operative)
Title
Hospital mortality
Description
Number of patient died in the first 30 days after surgery
Time Frame
First 30 post-operative days after surgery (post-operative)
Title
Intensive Care Unit Length of Stay
Description
Number of hours of ICU admission
Time Frame
First 30 post-operative days after surgery (post-operative)
Title
Hospital Length of Stay
Description
Number of days before hospital discharge
Time Frame
First 30 post-operative days after surgery (post-operative)
Title
Delayed Graft Function (DGF)
Description
Need for hemodialysis in first 7 postoperative days
Time Frame
First 7 post-operative days (post-operative)
Title
Graft survival
Time Frame
30 days after transplantation
Title
Post-operative delirium
Description
CAM-ICU positive (asses one time for a day in the first 5 postoperative days)
Time Frame
First 5 post-operative days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: First single or double kidney transplant from a cadaveric donor; ASA Class III-IV; Signature of informed consent. Exclusion Criteria: Patient with atrial fibrillation rhythm or high frequency tachyarrhythmias; Severe valvulopathies; Combined single/double kidney-liver-transplant; Patients in whom the need for monitoring would still be expected advanced, invasive or minimally invasive hemodynamic, regardless of the allocation to the study group; Inclusion in another study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Antonio Siniscalchi, MD
Phone
+390512143131
Email
antonio.siniscalchi@aosp.bo.it
First Name & Middle Initial & Last Name or Official Title & Degree
Lorenzo Querci, MD
Phone
+393933980223
Email
lorenzo.querci@studio.unibo.it
Facility Information:
Facility Name
IRCCS Azienda Ospedaliero-Universitaria di Bologna
City
Bologna
ZIP/Postal Code
40100
Country
Italy
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25500761
Citation
Biancofiore G, Cecconi M, Rocca GD. A web-based Italian survey of current trends, habits and beliefs in hemodynamic monitoring and management. J Clin Monit Comput. 2015 Oct;29(5):635-42. doi: 10.1007/s10877-014-9646-7. Epub 2014 Dec 12.
Results Reference
background
PubMed Identifier
27466988
Citation
Perilli V, Aceto P, Sacco T, Modesti C, Ciocchetti P, Vitale F, Russo A, Fasano G, Dottorelli A, Sollazzi L. Anaesthesiological strategies to improve outcome in liver transplantation recipients. Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3172-7.
Results Reference
background
PubMed Identifier
21884645
Citation
Vincent JL, Rhodes A, Perel A, Martin GS, Della Rocca G, Vallet B, Pinsky MR, Hofer CK, Teboul JL, de Boode WP, Scolletta S, Vieillard-Baron A, De Backer D, Walley KR, Maggiorini M, Singer M. Clinical review: Update on hemodynamic monitoring--a consensus of 16. Crit Care. 2011 Aug 18;15(4):229. doi: 10.1186/cc10291.
Results Reference
background
PubMed Identifier
20530615
Citation
Lobo SM, Rezende E, Knibel MF, Silva NB, Paramo JA, Nacul FE, Mendes CL, Assuncao M, Costa RC, Grion CC, Pinto SF, Mello PM, Maia MO, Duarte PA, Gutierrez F, Silva JM Jr, Lopes MR, Cordeiro JA, Mellot C. Early determinants of death due to multiple organ failure after noncardiac surgery in high-risk patients. Anesth Analg. 2011 Apr;112(4):877-83. doi: 10.1213/ANE.0b013e3181e2bf8e. Epub 2010 Jun 8.
Results Reference
background
PubMed Identifier
16749940
Citation
Pearse RM, Harrison DA, James P, Watson D, Hinds C, Rhodes A, Grounds RM, Bennett ED. Identification and characterisation of the high-risk surgical population in the United Kingdom. Crit Care. 2006;10(3):R81. doi: 10.1186/cc4928. Epub 2006 Jun 2.
Results Reference
background
PubMed Identifier
18489613
Citation
Jhanji S, Thomas B, Ely A, Watson D, Hinds CJ, Pearse RM. Mortality and utilisation of critical care resources amongst high-risk surgical patients in a large NHS trust. Anaesthesia. 2008 Jul;63(7):695-700. doi: 10.1111/j.1365-2044.2008.05560.x. Epub 2008 May 16.
Results Reference
background
PubMed Identifier
27004412
Citation
Fischer MO, Fiant AL, Boutros M, Flais F, Filipov T, Debroczi S, Pasqualini L, Rhanem T, Gerard JL, Guittet L, Hanouz JL, Alves A, Parienti JJ; PANEX3 study group. Perioperative hemodynamic optimization using the photoplethysmography in colorectal surgery (the PANEX3 trial): study protocol for a randomized controlled trial. Trials. 2016 Mar 22;17:159. doi: 10.1186/s13063-016-1278-4.
Results Reference
background
PubMed Identifier
20966436
Citation
Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011 Jun;112(6):1392-402. doi: 10.1213/ANE.0b013e3181eeaae5. Epub 2010 Oct 21.
Results Reference
background
PubMed Identifier
25759947
Citation
Gomez-Izquierdo JC, Feldman LS, Carli F, Baldini G. Meta-analysis of the effect of goal-directed therapy on bowel function after abdominal surgery. Br J Surg. 2015 May;102(6):577-89. doi: 10.1002/bjs.9747. Epub 2015 Mar 11.
Results Reference
background
PubMed Identifier
18031528
Citation
Walsh SR, Tang T, Bass S, Gaunt ME. Doppler-guided intra-operative fluid management during major abdominal surgery: systematic review and meta-analysis. Int J Clin Pract. 2008 Mar;62(3):466-70. doi: 10.1111/j.1742-1241.2007.01516.x. Epub 2007 Nov 21.
Results Reference
background

Learn more about this trial

Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant (HPI2022)

We'll reach out to this number within 24 hrs